FDA Approves First Gene Therapy for Bladder Cancer FDA Approves First Gene Therapy for Bladder Cancer
A clinical trial found that half of participants had a complete response to nadofaragene firadenovec (Adstiladrin).Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Clinical Trials | Gene Therapy | Genetics | Hematology